AGILENT TECHNOLOGIES, INC. company profile

Overview

Agilent Technologies, Inc. is a global life sciences, diagnostics, and applied markets company. It provides laboratory instruments, software, services, and consumables used across research, clinical and diagnostic testing, and applied analytical workflows. Its three principal segments are Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets, spanning areas such as chromatography, spectroscopy, lab services, consumables, and laboratory automation.[1]

Agilent states that its mission is “to advance quality of life” and that it supports customers in 110 countries.[4] Incorporated in 1999, the company became fully independent in 2000.[1][5] In fiscal 2025, Agilent reported $6.948 billion in revenue and approximately 18,100 employees.[6][7] [1]

Products & services

Agilent’s product portfolio includes liquid chromatography (LC) and LC/mass spectrometry (LC/MS) systems; gas chromatography (GC) and GC/MS instruments; spectroscopy and vacuum products; analytical software, laboratory automation, and consumables; and diagnostic and genomics products. Its FY2025 products category—defined as analytical instruments, software, and consumables—grew 6%, with growth led by contract development and manufacturing, LC, LC/MS, and consumables.[8] Segment revenue provides a broader performance mix that includes both products and services: in FY2025, Life Sciences & Diagnostics Markets generated $2.726 billion (39.2%), Agilent CrossLab $2.908 billion (41.9%), and Applied Markets $1.314 billion (18.9%).[6] For the first nine months of FY2026, the respective segments generated $2.157 billion (39.1%), $2.303 billion (41.8%), and $1.051 billion (19.1%).[9]

Specific offerings include the 1290 Infinity III LC System, a UHPLC platform designed for fast separations, retention-time precision, resolution, and low dispersion; the 6495D Triple Quadrupole LC/MS, designed for high-throughput analysis and very low-level detection; and the configurable 8890 GC System, which includes instrument diagnostics and built-in intelligence.[10] Its Dako Omnis platform automates pathology workflows including immunohistochemistry, immunofluorescence, and in situ hybridization, while the SureSelect XT HS2 DNA Reagent Kit supports target enrichment and library preparation for Illumina sequencing, including low-input and FFPE DNA workflows.[13][14] Agilent CrossLab services include instrument repair and preventive maintenance, compliance support, installation and relocation, laboratory consulting, and training; reported FY2025 growth in services and other revenue was 9%, led by repair and preventive maintenance.[15][16] [8]

Geographic presence

In the first nine months of FY2026, Agilent reported revenue across three regions: $2.203 billion in the Americas (40.0% of total revenue), $1.540 billion in Europe (27.9%), and $1.768 billion in Asia Pacific (32.1%). These figures describe regional, not country-level, revenue; the cited reporting does not provide a country-by-country breakdown.[9]

Agilent reported approximately 18,100 employees supporting customers in 110 countries in FY2025. Its listed locations include its headquarters in Santa Clara, California, and sites in Delaware, California, Germany, and Japan; the company also identifies logistics centers in Memphis, Waldbronn, and Singapore, along with nine additional regional hubs.[7][17] [9]

Business segments

Agilent reports three business segments. Its latest available 2026 reporting covers the nine months ended July 31, 2026; the percentages below are shares of segment revenue in consolidated revenue for that period.[18]

Life Sciences and Diagnostics Markets provides tools and workflows for clinical and life-sciences research, including liquid chromatography and LC-MS, cell analysis, genomics and biomolecular analysis; pathology and cancer-diagnostics products; and specialty CDMO and biomanufacturing services. It generated $2,157 million, approximately 39.1% of nine-month 2026 revenue; its FY2025 share was approximately 39.2%.[19]

Agilent CrossLab provides laboratory services, consumables, software and automation, including instrument repair and maintenance, installation, training, compliance support, SaaS, asset management and consulting. It generated $2,303 million, approximately 41.8% of nine-month 2026 revenue; its FY2025 share was approximately 41.9%.[3]

Applied Markets provides application-focused instruments and software for identifying, quantifying and analyzing substances and products. Its businesses include gas chromatography, GC-MS, remarketed instruments, spectroscopy and vacuum. It generated $1,051 million, approximately 19.1% of nine-month 2026 revenue; its FY2025 share was approximately 18.9%.[21] [18]

Company history

Agilent’s origins trace to Hewlett-Packard, founded by Bill Hewlett and Dave Packard in 1939. Hewlett-Packard announced Agilent as the name for its measurement company in 1999; Agilent’s shares began trading that November, and it became independent on June 2, 2000, when HP distributed its shares to HP shareholders.[22]

In 2001, Agilent sold its healthcare business to Philips. It expanded its analytical-instrument and diagnostics businesses with the 2010 acquisition of Varian and the 2012 acquisition of Dako. In 2014, Agilent spun off its electronic-measurement business as Keysight Technologies.[5]

In 2021, Agilent completed its acquisition of Resolution Bioscience, adding liquid-biopsy technology. In 2024, it completed the acquisition of BIOVECTRA, expanding its contract-development and manufacturing capabilities; that year, Padraig McDonnell succeeded Mike McMullen as president and CEO.[28] [22]

Continue your research

From company context to financial detail.

Explore original sources and worldwide fundamental financial data and intelligence with Finbar.

Explore AGILENT TECHNOLOGIES, INC. in Finbar ↗

AGILENT TECHNOLOGIES, INC.